Literature DB >> 7798892

Differences in the entire nucleotide sequence between hepatitis B virus genomes from carriers positive for antibody to hepatitis B e antigen with and without active disease.

M Horikita1, S Itoh, K Yamamoto, T Shibayama, F Tsuda, H Okamoto.   

Abstract

The entire nucleotide sequence was determined for eight hepatitis B virus (HBV) genomes from three symptom-free carriers, two patients with chronic persistent hepatitis and one patient with chronic active hepatitis, who were positive for antibody to hepatitis B e antigen (HBeAg). The two patients with chronic persistent hepatitis were tested again after they developed chronic active or fulminant hepatitis, making a total of eight samples. Six had a point mutation in the preC region prohibiting the encoding of HBeAg precursor, while the remaining two had a deletion of 8 or 21 nucleotides within the X gene upstream of the preC transcription initiation sites which would affect the X gene and the putative preC/C promoter. Most genomes from the three symptom-free carriers and the two patients with chronic persistent hepatitis, with HBV DNA levels of 10(2)-10(3)/ml, had deletion, frameshift mutation, initiation failure or a premature stop codon, rendering them replication-incompetent. In contrast, such mutations were rarely seen in HBV genomes from the two patients with chronic persistent hepatitis after they had developed active or fulminant hepatitis and from the patient with chronic active hepatitis, all of whom had vigorous HBV replication with serum HBV DNA from 10(6) to 10(9)/ml. Unique mutations for amino acid changes were more frequent in HBV genomes with a higher replicative activity. These results indicate two kinds of HBV genomes with an HBeAg-minus phenotype, one with defects seriously affecting viral replication and the other without such defects, which would account for different clinical profiles in carriers with antibody to HBeAg.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7798892     DOI: 10.1002/jmv.1890440118

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Mutations in Hepatitis-B X-Gene Region: Chronic Hepatitis-B versus Cirrhosis.

Authors:  Farzaneh Salarnia; Sima Besharat; Sare Zhand; Naeme Javid; Behnaz Khodabakhshi; Abdolvahab Moradi
Journal:  J Clin Diagn Res       Date:  2017-03-01

2.  Hepatitis B virus genomes of chronic hepatitis patients do not contain specific mutations related to acute exacerbation.

Authors:  W Li; H Ikematsu; T K Yamaji; Y Chong; J Hayashi; S Kashiwagi
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

3.  A male patient with severe acute hepatitis who was domestically infected with a genotype H hepatitis B virus in Iwate, Japan.

Authors:  Ichiro Kumagai; Koichi Abe; Takayoshi Oikawa; Akihiro Sato; Shinichiro Sato; Ryujin Endo; Yasuhiro Takikawa; Kazuyuki Suzuki; Tomoyuki Masuda; Shigehiko Sainokami; Kazunori Endo; Masaharu Takahashi; Hiroaki Okamoto
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

4.  Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.

Authors:  S Günther; N Piwon; A Iwanska; R Schilling; H Meisel; H Will
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Possible association of vigorous hepatitis B virus replication with the development of fulminant hepatitis.

Authors:  Kazuaki Inoue; Osamu Ogawa; Masaya Yamada; Tsunamasa Watanabe; Hiroaki Okamoto; Makoto Yoshiba
Journal:  J Gastroenterol       Date:  2006-04       Impact factor: 7.527

6.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

Authors:  H Okamoto; F Tsuda; Y Akahane; Y Sugai; M Yoshiba; K Moriyama; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  A revised secondary structure model for the 3'-end of hepatitis B virus pregenomic RNA.

Authors:  A H Kidd; K Kidd-Ljunggren
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

8.  HBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers.

Authors:  Bernal León; Lizeth Taylor; Minor Vargas; Ronald B Luftig; Federico Albertazzi; Libia Herrero; Kirsten Visona
Journal:  Virol J       Date:  2005-08-04       Impact factor: 4.099

9.  Tracing hepatitis B virus (HBV) genotype B5 (formerly B6) evolutionary history in the circumpolar Arctic through phylogeographic modelling.

Authors:  Remco Bouckaert; Brenna C Simons; Henrik Krarup; T Max Friesen; Carla Osiowy
Journal:  PeerJ       Date:  2017-08-31       Impact factor: 2.984

10.  Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences.

Authors:  Anna L McNaughton; Peter A Revill; Margaret Littlejohn; Philippa C Matthews; M Azim Ansari
Journal:  J Gen Virol       Date:  2020-03       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.